世界の疼痛管理装置市場2021年ｰ2028年：製品タイプ別（電気刺激装置[経皮的電気神経刺激{TENS}装置、神経筋電気刺激{NMES/EMS}装置、その他]、高周波アブレーション装置、鎮痛剤注入ポンプ[髄腔内注入ポンプ、外部注入ポンプ]、神経刺激装置[脊髄索刺激{SCS}装置、深部脳刺激装置、迷走神経刺激装置、仙骨神経刺激装置]）、用途別

• 英文タイトル：Pain Management Devices Market (Product Type: Electrical Stimulation Devices [Transcutaneous Electrical Nerve Stimulation {TENS} Devices, Neuromuscular Electrical Stimulation {NMES/EMS} Devices, and Other Electrical Stimulation Devices], Radiofrequency Ablation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], and Neurostimulation Devices [Spinal Cord Stimulation {SCS} Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, and Sacral Nerve Stimulation Devices; and Application: Electrical Stimulation Devices, Neurostimulation Devices, Analgesic Infusion Pump, and Radiofrequency Ablation Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

• レポートコード：MRC2205A018 • 出版社/出版日：Transparency Market Research / 2022年3月21日 • レポート形態：英文、PDF、241ページ • 納品方法：Eメール • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Multi User	￥1,301,660 (USD8,795)	▷ お問い合わせ
Corporate License	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Transparency Market Research社の本調査レポートは、世界の疼痛管理装置市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品タイプ別（電気刺激装置、高周波アブレーション装置、鎮痛剤注入ポンプ、神経刺激装置）分析、用途別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の疼痛管理装置市場規模：製品タイプ別（電気刺激装置、高周波アブレーション装置、鎮痛剤注入ポンプ、神経刺激装置） ・世界の疼痛管理装置市場規模：用途別 ・世界の疼痛管理装置市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況

Pain Management Device Market – Scope of Report

TMR’s report on the global pain management devices market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global pain management devices market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global pain management devices market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global pain management devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global pain management devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global pain management devices market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global pain management devices market.

The report delves into the competitive landscape of the global pain management devices market. Key players operating in the global pain management devices market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global pain management devices market that have been profiled in this report.

Key Questions Answered in Pain Management Devices Market Report
What is the scope of growth of product companies in the global pain management devices market?
What will be the Y-o-Y growth of the global pain management devices market between 2017 and 2028?
What is the influence of changing trends in technologies on the global pain management devices market?
Will North America be the most profitable market for pain management devices providers?
Which factors are anticipated to hamper the growth of the global pain management devices market during the forecast period?
Which are the leading companies in the global pain management devices market?

Research Methodology
TMR has utilized a unique research methodology to conduct a comprehensive research on the growth of the global pain management devices market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global pain management devices market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the pain management devices market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the pain management devices market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global pain management devices market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global pain management devices market more reliably and accurately.

レポート目次

---

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pain Management Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pain Management Devices Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
5.3. Regulatory Scenario by Region/globally
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Pain Management Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Electrical Stimulation Devices
6.3.1.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
6.3.1.2. Neuromuscular Electrical Stimulation (NMES/EMS) Devices
6.3.1.3. Other electrical stimulation devices (electrotherapy devices, combination devices, TNS, TMS, etc.)
6.3.2. Radiofrequency Ablation Devices
6.3.3. Analgesic Infusion Pumps
6.3.3.1. Intrathecal Infusion Pumps
6.3.3.2. External Infusion Pumps
6.3.4. Neurostimulation Devices
6.3.4.1. Spinal Cord Stimulation (SCS) Devices
6.3.4.2. Deep Brain Stimulation Devices
6.3.4.3. Vagus Nerve Stimulation Devices
6.3.4.4. Sacral Nerve Stimulation Devices
6.4. Market Attractiveness Analysis, by Product Type
7. Global Pain Management Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Electrical Stimulation Devices Market
7.3.1.1. Neuropathic Pain
7.3.1.2. Cancer Pain
7.3.1.3. Facial & Migraine
7.3.1.4. Musculoskeletal Pain
7.3.1.5. Trauma
7.3.2. Neurostimulation Devices Market
7.3.2.1. Neuropathic Pain
7.3.2.2. Cancer Pain
7.3.2.3. Facial & Migraine
7.3.2.4. Musculoskeletal Pain
7.3.3. Analgesic Infusion Pump Market
7.3.3.1. Neuropathic Pain
7.3.3.2. Cancer Pain
7.3.3.3. Trauma
7.3.3.4. Musculoskeletal Pain
7.3.4. Radiofrequency Ablation Devices
7.3.4.1. Neuropathic Pain
7.3.4.2. Cancer Pain
7.3.4.3. Musculoskeletal Pain
7.4. Market Attractiveness Analysis, by Application
8. Global Pain Management Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Pain Management Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017–2031
9.2.1. Electrical Stimulation Devices
9.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
9.2.1.2. Neuromuscular Electrical Stimulation (NMES/EMS) Devices
9.2.1.3. Other Electrical Stimulation Devices (Electrotherapy Devices, Combination Devices, TNS, TMS, etc.)
9.2.2. Radiofrequency Ablation Devices
9.2.3. Analgesic Infusion Pumps
9.2.3.1. Intrathecal Infusion Pumps
9.2.3.2. External Infusion Pumps
9.2.4. Neurostimulation Devices
9.2.4.1. Spinal Cord Stimulation (SCS) Devices
9.2.4.2. Deep Brain Stimulation Devices
9.2.4.3. Vagus Nerve Stimulation Devices
9.2.4.4. Sacral Nerve Stimulation Devices
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Electrical Stimulation Devices Market
9.3.1.1. Neuropathic Pain
9.3.1.2. Cancer Pain
9.3.1.3. Facial & Migraine
9.3.1.4. Musculoskeletal Pain
9.3.1.5. Trauma
9.3.2. Neurostimulation Devices Market
9.3.2.1. Neuropathic Pain
9.3.2.2. Cancer Pain
9.3.2.3. Facial & Migraine
9.3.2.4. Musculoskeletal Pain
9.3.3. Analgesic Infusion Pump Market
9.3.3.1. Neuropathic Pain
9.3.3.2. Cancer Pain
9.3.3.3. Trauma
9.3.3.4. Musculoskeletal Pain
9.3.4. Radiofrequency Ablation Devices
9.3.4.1. Neuropathic Pain
9.3.4.2. Cancer Pain
9.3.4.3. Musculoskeletal Pain
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Application
9.5.3. By Country
10. Europe Pain Management Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Electrical Stimulation Devices
10.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
10.2.1.2. Neuromuscular Electrical Stimulation (NMES/EMS) Devices
10.2.1.3. Other Electrical Stimulation Devices (Electrotherapy Devices, Combination Devices, TNS, TMS, etc.)
10.2.2. Radiofrequency Ablation Devices
10.2.3. Analgesic Infusion Pumps
10.2.3.1. Intrathecal Infusion Pumps
10.2.3.2. External Infusion Pumps
10.2.4. Neurostimulation Devices
10.2.4.1. Spinal Cord Stimulation (SCS) Devices
10.2.4.2. Deep Brain Stimulation Devices
10.2.4.3. Vagus Nerve Stimulation Devices
10.2.4.4. Sacral Nerve Stimulation Devices
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Electrical Stimulation Devices Market
10.3.1.1. Neuropathic Pain
10.3.1.2. Cancer Pain
10.3.1.3. Facial & Migraine
10.3.1.4. Musculoskeletal Pain
10.3.1.5. Trauma
10.3.2. Neurostimulation Devices Market
10.3.2.1. Neuropathic Pain
10.3.2.2. Cancer Pain
10.3.2.3. Facial & Migraine
10.3.2.4. Musculoskeletal Pain
10.3.3. Analgesic Infusion Pump Market
10.3.3.1. Neuropathic Pain
10.3.3.2. Cancer Pain
10.3.3.3. Trauma
10.3.3.4. Musculoskeletal Pain
10.3.4. Radiofrequency Ablation Devices
10.3.4.1. Neuropathic Pain
10.3.4.2. Cancer Pain
10.3.4.3. Musculoskeletal Pain
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Pain Management Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Electrical Stimulation Devices
11.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
11.2.1.2. Neuromuscular Electrical Stimulation (NMES/EMS) Devices
11.2.1.3. Other electrical stimulation devices (electrotherapy devices, combination devices, TNS, TMS, etc.)
11.2.2. Radiofrequency Ablation Devices
11.2.3. Analgesic Infusion Pumps
11.2.3.1. Intrathecal Infusion Pumps
11.2.3.2. External Infusion Pumps
11.2.4. Neurostimulation Devices
11.2.4.1. Spinal Cord Stimulation (SCS) Devices
11.2.4.2. Deep Brain Stimulation Devices
11.2.4.3. Vagus Nerve Stimulation Devices
11.2.4.4. Sacral Nerve Stimulation Devices
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Electrical Stimulation Devices Market
11.3.1.1. Neuropathic Pain
11.3.1.2. Cancer Pain
11.3.1.3. Facial & Migraine
11.3.1.4. Musculoskeletal Pain
11.3.1.5. Trauma
11.3.2. Neurostimulation Devices Market
11.3.2.1. Neuropathic Pain
11.3.2.2. Cancer Pain
11.3.2.3. Facial & Migraine
11.3.2.4. Musculoskeletal Pain
11.3.3. Analgesic Infusion Pump Market
11.3.3.1. Neuropathic Pain
11.3.3.2. Cancer Pain
11.3.3.3. Trauma
11.3.3.4. Musculoskeletal Pain
11.3.4. Radiofrequency Ablation Devices
11.3.4.1. Neuropathic Pain
11.3.4.2. Cancer Pain
11.3.4.3. Musculoskeletal Pain
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Pain Management Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Electrical Stimulation Devices
12.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
12.2.1.2. Neuromuscular Electrical Stimulation (NMES/EMS) Devices
12.2.1.3. Other electrical stimulation devices (electrotherapy devices, combination devices, TNS, TMS, etc.)
12.2.2. Radiofrequency Ablation Devices
12.2.3. Analgesic Infusion Pumps
12.2.3.1. Intrathecal Infusion Pumps
12.2.3.2. External Infusion Pumps
12.2.4. Neurostimulation Devices
12.2.4.1. Spinal Cord Stimulation (SCS) Devices
12.2.4.2. Deep Brain Stimulation Devices
12.2.4.3. Vagus Nerve Stimulation Devices
12.2.4.4. Sacral Nerve Stimulation Devices
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Electrical Stimulation Devices Market
12.3.1.1. Neuropathic Pain
12.3.1.2. Cancer Pain
12.3.1.3. Facial & Migraine
12.3.1.4. Musculoskeletal Pain
12.3.1.5. Trauma
12.3.2. Neurostimulation Devices Market
12.3.2.1. Neuropathic Pain
12.3.2.2. Cancer Pain
12.3.2.3. Facial & Migraine
12.3.2.4. Musculoskeletal Pain
12.3.3. Analgesic Infusion Pump Market
12.3.3.1. Neuropathic Pain
12.3.3.2. Cancer Pain
12.3.3.3. Trauma
12.3.3.4. Musculoskeletal Pain
12.3.4. Radiofrequency Ablation Devices
12.3.4.1. Neuropathic Pain
12.3.4.2. Cancer Pain
12.3.4.3. Musculoskeletal Pain
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Pain Management Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Electrical Stimulation Devices
13.2.1.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
13.2.1.2. Neuromuscular Electrical Stimulation (NMES/EMS) Devices
13.2.1.3. Other electrical stimulation devices (electrotherapy devices, combination devices, TNS, TMS, etc.)
13.2.2. Radiofrequency Ablation Devices
13.2.3. Analgesic Infusion Pumps
13.2.3.1. Intrathecal Infusion Pumps
13.2.3.2. External Infusion Pumps
13.2.4. Neurostimulation Devices
13.2.4.1. Spinal Cord Stimulation (SCS) Devices
13.2.4.2. Deep Brain Stimulation Devices
13.2.4.3. Vagus Nerve Stimulation Devices
13.2.4.4. Sacral Nerve Stimulation Devices
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Electrical Stimulation Devices Market
13.3.1.1. Neuropathic Pain
13.3.1.2. Cancer Pain
13.3.1.3. Facial & Migraine
13.3.1.4. Musculoskeletal Pain
13.3.1.5. Trauma
13.3.2. Neurostimulation Devices Market
13.3.2.1. Neuropathic Pain
13.3.2.2. Cancer Pain
13.3.2.3. Facial & Migraine
13.3.2.4. Musculoskeletal Pain
13.3.3. Analgesic Infusion Pump Market
13.3.3.1. Neuropathic Pain
13.3.3.2. Cancer Pain
13.3.3.3. Trauma
13.3.3.4. Musculoskeletal Pain
13.3.4. Radiofrequency Ablation Devices
13.3.4.1. Neuropathic Pain
13.3.4.2. Cancer Pain
13.3.4.3. Musculoskeletal Pain
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. Baxter International, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Analysis
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. Bio-Medical Research (BMR) Ltd.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Analysis
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Boston Scientific Corporation
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Analysis
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. DJO Global, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Analysis
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Medtronic plc
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Analysis
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Stryker Corporation
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Analysis
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. B. Braun Melsungen AG
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Analysis
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. Avanos Medical, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Analysis
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. Microtransponde.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Analysis
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis

---